Editorial: Clinical therapy of brain tumors.
作者信息
Huang Boyuan, Zhao Huijun, Yang Jun, Liu Fusheng, Caruso Gerardo, Zhang Hongbo, Chen Lin
机构信息
Second Department of Neurosurgery, Capital Medical University Electric Power Teaching Hospital/State GridBeijing Electric Power Hospital, Beijing, China.
Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
出版信息
Front Neurol. 2025 May 23;16:1610463. doi: 10.3389/fneur.2025.1610463. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Clinical therapy of brain tumors.社论：脑肿瘤的临床治疗
Front Neurol. 2025 May 23;16:1610463. doi: 10.3389/fneur.2025.1610463. eCollection 2025.
2
3
Treatment outcome of patients with brain metastases from malignant germ cell tumors.恶性生殖细胞肿瘤脑转移患者的治疗结果
Cancer. 1999 Feb 15;85(4):988-97. doi: 10.1002/(sici)1097-0142(19990215)85:4<988::aid-cncr29>3.0.co;2-r.
4
Brain metastasis treatment guidelines: consensus by the Spanish Society of Neurosurgery Tumor Section.脑转移瘤治疗指南：西班牙神经外科学会肿瘤分会共识。
Neurocirugia (Astur : Engl Ed). 2023 Nov-Dec;34(6):308-320. doi: 10.1016/j.neucie.2023.07.010. Epub 2023 Oct 12.
5
Immunological effects of chemotherapy and radiotherapy against brain tumors.化疗和放疗对脑肿瘤的免疫作用。
Expert Rev Anticancer Ther. 2016 Oct;16(10):1087-94. doi: 10.1080/14737140.2016.1229600. Epub 2016 Sep 6.
6
The neurosurgeon as local oncologist: cellular and molecular neurosurgery in malignant glioma therapy.神经外科医生作为局部肿瘤学家：恶性胶质瘤治疗中的细胞与分子神经外科手术
Neurosurgery. 2003 Jun;52(6):1411-22; discussion 1422-4. doi: 10.1227/01.neu.0000064808.27512.cf.
7
[Combination of tumors of different histogenesis in pediatric neurosurgery].[小儿神经外科中不同组织发生的肿瘤组合]
Zh Vopr Neirokhir Im N N Burdenko. 2021;85(2):80-90. doi: 10.17116/neiro20218502180.
8
Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.联合细胞毒性和免疫介导的基因疗法治疗脑肿瘤。
Curr Top Med Chem. 2005;5(12):1151-70. doi: 10.2174/156802605774370856.
9
Editorial: Radiotherapy strategies for precise treatment on brain metastases.社论：脑转移瘤精确治疗的放疗策略
Front Oncol. 2024 Mar 20;14:1366261. doi: 10.3389/fonc.2024.1366261. eCollection 2024.
10
A literature review of the recent radiotherapy clinical trials in pediatric brain tumors.
Rev Recent Clin Trials. 2009 Jan;4(1):42-55. doi: 10.2174/157488709787047567.
本文引用的文献
1
NCCN CNS tumor guidelines update for 2023.2023年美国国立综合癌症网络（NCCN）中枢神经系统肿瘤指南更新
Neuro Oncol. 2023 Dec 8;25(12):2114-2116. doi: 10.1093/neuonc/noad169.
2
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.沃拉西尼布治疗 IDH1 或 IDH2 突变型低级别胶质瘤。
N Engl J Med. 2023 Aug 17;389(7):589-601. doi: 10.1056/NEJMoa2304194. Epub 2023 Jun 4.
3
Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment.肿瘤电场（TTFields）疗法联合紫杉烷类药物用于癌症治疗。
Cancers (Basel). 2023 Jan 19;15(3):636. doi: 10.3390/cancers15030636.
4
Proton radiotherapy for glioma and glioblastoma.用于胶质瘤和胶质母细胞瘤的质子放疗
Chin Clin Oncol. 2022 Dec;11(6):46. doi: 10.21037/cco-22-92.
5
Proton radiotherapy in the treatment of IDH-mutant diffuse gliomas: an early experience from shanghai proton and heavy ion center.质子放疗治疗 IDH 突变型弥漫性 gliomas：上海质子重离子中心的早期经验。
J Neurooncol. 2023 May;162(3):503-514. doi: 10.1007/s11060-022-04202-5. Epub 2022 Dec 30.
6
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.自体肿瘤裂解物负载树突状细胞疫苗接种与新诊断和复发性胶质母细胞瘤患者生存延长的相关性：一项 3 期前瞻性外部对照队列试验。
JAMA Oncol. 2023 Jan 1;9(1):112-121. doi: 10.1001/jamaoncol.2022.5370.
7
Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.瘤内溶瘤单纯疱疹病毒 G47∆ 治疗残留或复发性脑胶质瘤：一项 2 期试验
Nat Med. 2022 Aug;28(8):1630-1639. doi: 10.1038/s41591-022-01897-x. Epub 2022 Jul 21.
8
FDA Approval Summary: Entrectinib for the Treatment of gene Fusion Solid Tumors.FDA 批准概要：恩曲替尼治疗基因融合型实体瘤。
Clin Cancer Res. 2021 Feb 15;27(4):928-932. doi: 10.1158/1078-0432.CCR-20-2771. Epub 2020 Sep 23.
9
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.纳武利尤单抗对比贝伐珠单抗治疗复发性胶质母细胞瘤患者的效果：CheckMate 143 期随机临床试验。
JAMA Oncol. 2020 Jul 1;6(7):1003-1010. doi: 10.1001/jamaoncol.2020.1024.
10
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.拉罗替尼治疗 TRK 融合阳性实体瘤患者的疗效：三项 I/II 期临床试验的汇总分析。
Lancet Oncol. 2020 Apr;21(4):531-540. doi: 10.1016/S1470-2045(19)30856-3. Epub 2020 Feb 24.
Zotero 插件